Audicus Applauds FDA Announcement To Move Closer To Making Hearing Care More Accessible To Millions Of Americans

First Company To Offer Fully Customizable Hearing Aids Online

Audicus, the first company to offer fully customizable hearing aids online, and a leading provider of hearing aids via telehealth, responded today to the FDA’s proposed rule to establish a new category of over-the-counter (OTC) hearing aids. The proposed rule will allow for certain classes of hearing aids to be sold directly to consumers without the need for a fitting from an Audiologist, increasing accessibility to hearing care for the 37.5 million American adults with some form of hearing loss.

“Audicus pioneered the movement in making high quality hearing care more accessible and affordable nearly a decade ago,” said Patrick Freuler, Founder and CEO of Audicus. “We welcome the FDA’s proposed rule to create a class of OTC hearing aids and see it as a milestone towards greater access. This decision could only allow us to further reach those in need of hearing solutions, and deliver life-changing devices to them at a fraction of the cost of traditional channels,” he continued.

Throughout the COVID-19 pandemic, Audicus has seen the increased need to provide quality telehealth services, as well as a positive shift in seniors’ attitudes towards technology. In a survey of 330 seniors, Audicus found that 16% have used telemedicine services since the start of the pandemic, as compared to 5% before. Furthermore, 25% of seniors report now making video calls, as compared to 15% before. With this FDA proposal, Audicus recognizes that ongoing support through technology will be even more important for OTC hearing aids.

“We have helped hundreds of thousands of seniors learn about their hearing through our proprietary online hearing assessment and educational programming,” said Freuler, “and we look forward to continuing to provide expert care and support to the millions of seniors who are in need of hearing care.”

SourceAudicus
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

PolarisAR describes STELLAR Knee as a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.
This February, the first enrolled patient underwent open surgical aortic arch reconstruction at the University of Pennsylvania, Presbyterian Medical Center, Philadelphia, PA.  During the surgery, the Duett Vascular Graft System was successfully deployed to connect the native left common carotid artery to the surgical graft.
"Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium channel blockers, and long-acting nitrates while also potentially enhancing control of the underlying coronary disease and reducing angina related hospitalizations.
The rehabilitation robotic glove is a training device that combines EMG electromyographic feedback and flexible robotics for patients with stroke or hand disabilities to train and repair dexterity.

By using this website you agree to accept Medical Device News Magazine Privacy Policy